CCA
LLY icon

Cora Capital Advisors’s Eli Lilly LLY Stock Holding History

Cora Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24M Buy
1,343
+66
+5% +$66.9K 0.41% 36
2025
Q4 		$1.37M Buy
1,277
+98
+8% +$93.7K 0.53% 33
2025
Q3 		$899K Buy
1,179
+16
+1% +$11.9K 0.38% 42
2025
Q2 		$907K Buy
1,163
+130
+13% +$101K 0.4% 40
2025
Q1 		$853K Buy
1,033
+21
+2% +$17.5K 0.41% 42
2024
Q4 		$781K Buy
1,012
+35
+4% +$29K 0.38% 47
2024
Q3 		$866K Buy
977
+36
+4% +$32.4K 0.43% 45
2024
Q2 		$852K Buy
941
+7
+0.7% +$5.6K 0.44% 42
2024
Q1 		$726K Sell
934
-62
-6% -$44.1K 0.39% 47
2023
Q4 		$580K Sell
996
-2
-0.2% -$1.17K 0.34% 49
2023
Q3 		$536K Sell
998
-112
-10% -$57.7K 0.36% 49
2023
Q2 		$521K Buy
1,110
+154
+16% +$64.6K 0.35% 53
2023
Q1 		$328K Buy
956
+26
+3% +$8.77K 0.24% 56
2022
Q4 		$340K Buy
+930
New +$330K 0.23% 51

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Cora Capital Advisors's LLY Position: Q1 2026 in Review

Cora Capital Advisors increased its Eli Lilly (LLY) stake by 5.2% in Q1 2026, buying an estimated $66.9K and bringing the position to 1,343 shares worth $1.24M. The position accounts for 0.41% of the portfolio, ranked #36.

Cora Capital Advisors first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.37M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cora Capital Advisors held 1,343 shares of Eli Lilly worth $1.24M as of Q1 2026.
  • Cora Capital Advisors bought 66 Eli Lilly shares in Q1 2026, an estimated $66.9K.
  • Eli Lilly made up 0.41% of Cora Capital Advisors's portfolio in Q1 2026, its #36 holding.
  • Cora Capital Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Cora Capital Advisors's Eli Lilly position peaked at $1.37M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cora Capital Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.